UK malaria treatment guidelines 2016.
Lalloo DG, Shingadia D, Bell DJ, Beeching NJ, Whitty CJM, Chiodini PL; PHE Advisory Committee on Malaria Prevention in UK Travellers.
J Infect. 2016 Jun;72(6):635-649. doi: 10.1016/j.jinf.2016.02.001. Epub 2016 Feb 12.
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K, Williams J, Qi YP, Gutman J, Yeung L, Mai C, Finkelstain J, Mehta S, Pons-Duran C, Menéndez C, Moraleda C, Rogers L, Daniels K, Green P.
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
Hepatic Capillariasis- Drug Targets.
Dubey A, Bagchi A, Sharma D, Dey A, Nandy K, Sharma R.
Infect Disord Drug Targets. 2018;18(1):3-10. doi: 10.2174/1871526517666170427124254.
Malaria vaccines: facing unknowns.
Palacpac NMQ, Horii T.
F1000Res. 2020 Apr 27;9:F1000 Faculty Rev-296. doi: 10.12688/f1000research.22143.1. eCollection 2020.
Trichomoniasis and adverse birth outcomes: a systematic review and meta-analysis.
Van Gerwen OT, Craig-Kuhn MC, Jones AT, Schroeder JA, Deaver J, Buekens P, Kissinger PJ, Muzny CA.
BJOG. 2021 Nov;128(12):1907-1915. doi: 10.1111/1471-0528.16774. Epub 2021 Jun 27.
Congenital toxoplasmosis.
Kieffer F, Wallon M.
Handb Clin Neurol. 2013;112:1099-101. doi: 10.1016/B978-0-444-52910-7.00028-3.
Lymphatic filariasis and onchocerciasis.
Taylor MJ, Hoerauf A, Bockarie M.
Lancet. 2010 Oct 2;376(9747):1175-85. doi: 10.1016/S0140-6736(10)60586-7. Epub 2010 Aug 23.
Management of malaria in pregnancy.
Rogerson SJ.
Indian J Med Res. 2017 Sep;146(3):328-333. doi: 10.4103/ijmr.IJMR_1304_17.
Leishmaniases: Strategies in treatment development.
Majoor A, Michel G, Marty P, Boyer L, Pomares C.
Parasite. 2025;32:18. doi: 10.1051/parasite/2025009. Epub 2025 Mar 5.
Malaria vaccine development.
Jones TR, Hoffman SL.
Clin Microbiol Rev. 1994 Jul;7(3):303-10. doi: 10.1128/CMR.7.3.303.
